The biggest microbiome market may not be a microbiome market.
The sector can keep creating more companies built around microbiome science. A much larger opportunity may come from businesses embedding microbiome capabilities inside something customers already value.
The category is not the market.
Sector growth has usually been read through visible markers: more microbiome companies, more tests, more therapeutics and more products carrying the word microbiome. Those things can keep growing. But they are only one part of the addressable opportunity.
Invisible capability can create visible value.
Microbiome capability can sit inside nutrition, therapeutics, diagnostics, longevity, food, consumer health and other propositions without becoming the category the customer is asked to buy. The outcome can matter more than whether the enabling layer is visible.
Build the product, enable someone else’s, or do both.
The strategic question is no longer only how to win inside a microbiome category. It is where microbiome capability can make another business stronger, and which position in that value chain creates the most durable value.
Where could microbiome capability create value even if the customer never sees the word microbiome?
That question changes who the buyer is, what the proposition becomes and how far the addressable market extends.
Growth can happen inside the sector and beyond its boundaries at the same time.
More microbiome companies.
More microbiome-enabled businesses.
From Bridgyz, occasionally.
Perspectives, Executive Briefings and other things worth sharing.